GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Natus Medical Inc (NAS:NTUS) » Definitions » Current Ratio

Natus Medical (Natus Medical) Current Ratio : 2.54 (As of Mar. 2022)


View and export this data going back to 2001. Start your Free Trial

What is Natus Medical Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Natus Medical's current ratio for the quarter that ended in Mar. 2022 was 2.54.

Natus Medical has a current ratio of 2.54. It generally indicates good short-term financial strength.

The historical rank and industry rank for Natus Medical's Current Ratio or its related term are showing as below:

NTUS's Current Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.725
* Ranked among companies with meaningful Current Ratio only.

Natus Medical Current Ratio Historical Data

The historical data trend for Natus Medical's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Natus Medical Current Ratio Chart

Natus Medical Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.32 2.14 1.89 1.86 2.42

Natus Medical Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.95 2.40 2.52 2.42 2.54

Competitive Comparison of Natus Medical's Current Ratio

For the Medical Devices subindustry, Natus Medical's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Natus Medical's Current Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Natus Medical's Current Ratio distribution charts can be found below:

* The bar in red indicates where Natus Medical's Current Ratio falls into.



Natus Medical Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Natus Medical's Current Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Current Ratio (A: Dec. 2021 )=Total Current Assets (A: Dec. 2021 )/Total Current Liabilities (A: Dec. 2021 )
=277.291/114.601
=2.42

Natus Medical's Current Ratio for the quarter that ended in Mar. 2022 is calculated as

Current Ratio (Q: Mar. 2022 )=Total Current Assets (Q: Mar. 2022 )/Total Current Liabilities (Q: Mar. 2022 )
=286.768/112.855
=2.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Natus Medical  (NAS:NTUS) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Natus Medical Current Ratio Related Terms

Thank you for viewing the detailed overview of Natus Medical's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Natus Medical (Natus Medical) Business Description

Traded in Other Exchanges
N/A
Address
3150 Pleasant View Road, Middleton, WI, USA, 53562
Natus Medical Inc is a provider of newborn care, neurology, and hearing and balance assessment healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. It is divided into three business units: Neuro, Newborn Care, and Hearing and Balance. The company generates a majority of its revenue from the Neurology business unit which includes products and services that provide diagnostic, therapeutic and surgical solutions in neurodiagnostics, neurocritical care, and neurosurgery.
Executives
Chung Dong Chune Christopher officer: Vice President Medical Affairs 1501 INDUSTRIAL ROAD SAN CARLOS CA 94070
Bryant M Moore director 181 HARVEST LANE PITTSBORO NC 27312
Eric Guerin director 1950 HASSELL ROAD, HOFFMAN ESTATES IL 60169
Ilan Daskal director 1000 ALFRED NOBEL DRIVE, HERCULES CA 94547
Alice D. Schroeder director 1573 MALLORY LANE, SUITE 100, BRENTWOOD TN 37027
Lisa Wipperman Heine director 1244 76TH STREET WEST, INVER GROVE HEIGHTS MN 55077
Jonathan Kennedy director, officer: Sr. VP, CFO INTERSIL CORPORATION, 1001 MURPHY RANCH ROAD, MILPITAS CA 95035
Ken Ludlum director
Robert A Gunst director
Noll Austin Francis Iii officer: VP/GM Neurology 9805 FALLEN LEAF DRIVE MIDDLETON WI 53562
Thomas Joseph Sullivan director 64 PETTIT PL PRINCETON NJ 08540
Benjamin Drew Davies officer: Sr. VP, CFO 1501 INDUSTRIAL ROAD, SAN CARLOS X1 94070
Joshua Levine director 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Sharon Villaverde officer: Interim CFO 11780 U.S. HIGHWAY 1, SUITE 600, PALM BEACH GARDENS FL 33408
William M Moore director